Pharmaceuticals, Biotechnology and Life Sciences
Total product and royalty revenues of $534 million (+24% vs. Q3 2018) and Jakafi® (ruxolitinib) revenues of $433 million (+25%…
FRIENDSWOOD, Texas–(BUSINESS WIRE)–Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment…
— Renowned Genetics Researcher Dr. Michael Hayden Appointed Scientific Advisory Board Chair — CAMBRIDGE, Mass.–(BUSINESS WIRE)–CAMP4 Therapeutics, a biotechnology company…
BOSTON–(BUSINESS WIRE)–Gelesis, a biotechnology company developing a novel hydrogel platform technology to treat obesity and other chronic diseases related to…
VIENNA, Va.–(BUSINESS WIRE)–CEL-SCI Corporation (NYSE American: CVM), a Phase 3 cancer immunotherapy company, today announced that Geert Kersten, Chief Executive…
Sales of $577 million were flat as reported and grew 1% in constant currency Pharmaceutical growth of 3%, partially offset…
Third-Quarter 2019 Worldwide Sales Were $12.4 Billion, an Increase of 15%; Sales Increased 16% Excluding Impact from Foreign Exchange; Growth…
DUBLIN–(BUSINESS WIRE)–The “Flow Cytometry – Market Analysis, Trends, and Forecasts” report has been added to ResearchAndMarkets.com’s offering. The Flow Cytometry…
Data demonstrate potent efficacy and favourable toxicity profile of a reduced potency, sequence-selective DNA mono-alkylator Represents a promising new approach…
— Coalition for Epidemic Preparedness Innovations (CEPI) partnership will support Themis’ development and manufacturing of vaccine candidate — VIENNA, Austria…